600196.SS
$26.48
$
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, metabolism, alimentary and central nervous system. It also provides medical devices and diagnostic products. In addition, the company offers health care and hospital management services. Further, it engages in retail and wholesale distribution of medicines. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
Next Earnings
2026-02-25
Beta
0.728
Average Volume
Market Cap
Last Dividend
CIK
ISIN
CNE000000X38
CUSIP
CEO
Yi Liu
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Full Time Employees
40557
IPO Date
1998-08-07
Status
Active
Latest News
| Title | Headline | Publisher | Date |
|---|---|---|---|
| ElpasBio and Fosun Kairos Announce Commercialization Collaboration for AlloJoin® Stem Cell Therapy | /PRNewswire/ -- ElpasBio Holdings ("ElpasBio"), a leading clinical-stage biotechnology company focused on regenerative medicine, today announced that it has | PRNewsWire | 2026-01-13 19:01:00 |
Algorithm Performance
| Algorithm | Profit/Loss | Profit Factor | # Trades | Sharpe | Sortino | Efficiency |
|---|